Skip to main content

Table 10 Results of specificity

From: Development and validation of RP-HPLC method for estimation of brexpiprazole in its bulk and tablet dosage form using Quality by Design approach

Description

Observation

Acceptance criteria

Conclusion

Blank

No interference at R.T. of brexpiprazole in blank

No interference at R.T.

Developed chromatographic method passed the criteria for specificity.

Standard solution

Peak purity was 0.998

Peak purity: NLT 0.95

Sample solution

Peak purity was 0.998

Peak purity: NLT 0.95

Placebo

No interference at R.T. of brexpiprazole in placebo

No interference at R.T.